These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 6263987)

  • 21. Enzyme-linked immunosorbent assay for susceptibility to varicella.
    Shehab Z; Brunell PA
    J Infect Dis; 1983 Sep; 148(3):472-6. PubMed ID: 6311911
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Antibody response to varicella-zoster virus surface glycoproteins in chickenpox and shingles.
    Larkin M; Heckels JE; Ogilvie MM
    J Gen Virol; 1985 Aug; 66 ( Pt 8)():1785-93. PubMed ID: 2991441
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Detection of antibodies to varicella-zoster virus proteins in sera from the elderly.
    Vafai A; Mahalingam R; Zerbe G; Wellish M; Gilden DH
    Gerontology; 1988; 34(5-6):242-9. PubMed ID: 2851500
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Enzyme-linked immunosorbent assay for detection of virus-specific IgM antibodies to varicella-zoster virus.
    Hacham M; Leventon-Kriss S; Sarov I
    Intervirology; 1980; 13(4):214-22. PubMed ID: 6248482
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Should patients with zoster receive zoster immune globulin?
    Uduman SA; Gershon AA; Brunell PA
    JAMA; 1975 Dec; 234(10):1049-51. PubMed ID: 171458
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Antibodies to the three major glycoproteins of varicella-zoster virus: search for the relevant host immune response.
    Brunell PA; Novelli VM; Keller PM; Ellis RW
    J Infect Dis; 1987 Sep; 156(3):430-5. PubMed ID: 3039010
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Clinical reinfection with varicella-zoster virus.
    Gershon AA; Steinberg SP; Gelb L
    J Infect Dis; 1984 Feb; 149(2):137-42. PubMed ID: 6321605
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Antibodies to varicella-zoster virus glycoproteins I, II, and III in leukemic and healthy children.
    LaRussa PS; Gershon AA; Steinberg SP; Chartrand SA
    J Infect Dis; 1990 Sep; 162(3):627-33. PubMed ID: 2167335
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Zoster immune globulin prophylaxis of disseminated zoster in compromised hosts. A randomized trial.
    Stevens DA; Merigan TC
    Arch Intern Med; 1980 Jan; 140(1):52-4. PubMed ID: 6153260
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Biologic and immunologic characterization of the soluble skin-test antigen of varicella-zoster virus.
    Shiraki K; Yamanishi K; Takahashi M
    J Infect Dis; 1984 Apr; 149(4):501-4. PubMed ID: 6327833
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Management of varicella exposure in a neonatal intensive care unit.
    Lipton SV; Brunell PA
    JAMA; 1989 Mar 24-31; 261(12):1782-4. PubMed ID: 2537441
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Immunoglobulin subclass antibodies to varicella-zoster virus.
    Asano Y; Hiroishi Y; Itakura N; Hirose S; Kajita Y; Nagai T; Yazaki T; Takahashi M
    Pediatrics; 1987 Dec; 80(6):933-6. PubMed ID: 2825110
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cellular and humoral immunity to varicella zoster virus glycoproteins in immune and susceptible human subjects.
    Giller RH; Winistorfer S; Grose C
    J Infect Dis; 1989 Dec; 160(6):919-28. PubMed ID: 2555419
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Varicella-zoster virus-specific immunity after herpes zoster.
    Hayward A; Levin M; Wolf W; Angelova G; Gilden D
    J Infect Dis; 1991 Apr; 163(4):873-5. PubMed ID: 1849165
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Immobilization of viral antigens on filter paper for a [125I]staphylococcal protein A immunoassay: a rapid and sensitive technique for detection of herpes simplex virus antigens and antiviral antibodies.
    Cleveland PH; Richman DD; Oxman MN; Wickham MG; Binder PS; Worthen DM
    J Immunol Methods; 1979; 29(4):369-86. PubMed ID: 229166
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Characteristics of the complement-fixing antibody response for varicella-zoster virus in patients with herpes zoster].
    Trivello R; Peserico A; Moschen ME; Romano M
    Ann Sclavo; 1977; 19(6):1133-43. PubMed ID: 218503
    [No Abstract]   [Full Text] [Related]  

  • 37. Management of varicella-zoster contact and infection in pregnancy using a standardized varicella-zoster ELISA test.
    Enders G
    Postgrad Med J; 1985; 61 Suppl 4():23-30. PubMed ID: 3014475
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cell-mediated immunity to varicella-zoster virus demonstrated by lymphocyte transformation in herpes zoster.
    Hata S
    J Dermatol; 1983 Feb; 10(1):13-6. PubMed ID: 6306084
    [No Abstract]   [Full Text] [Related]  

  • 39. Immune response and tolerability of varicella vaccine in children and adolescents with systemic lupus erythematosus previously exposed to varicella-zoster virus.
    Barbosa CM; Terreri MT; Rosário PO; de Moraes-Pinto MI; Silva CA; Hilário MO
    Clin Exp Rheumatol; 2012; 30(5):791-8. PubMed ID: 22935227
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Varicella-zoster virus. Prospects for active immunization.
    Gershon AA
    Am J Clin Pathol; 1978 Jul; 70(1 Suppl):170-4. PubMed ID: 210654
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.